Stock comparison
QUEST DIAGNOSTICS INC is 4.9x more valuable than VERACYTE, INC. by market capitalization ($23.03 B vs $4.73 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DGX is larger
QUEST DIAGNOSTICS INC is 4.9x more valuable than VERACYTE, INC. by market capitalization ($23.03 B vs $4.73 B).
Market value leader
DGX
QUEST DIAGNOSTICS INC is 4.9x more valuable than VERACYTE, INC. by market capitalization ($23.03 B vs $4.73 B).
Revenue leader
DGX
VCYT: $517.14M vs DGX: $11.04B.
Profit leader
DGX
VCYT: $66.40M vs DGX: $992.00M.
Margin leader
VCYT
VCYT: 12.8% vs DGX: 9.0% net margin.
| Metric | VCYT | DGX |
|---|---|---|
| Market cap | $4.73 B | $23.03 B |
| US-listed rank | #1462 | #573 |
| Revenue (latest FY) | $517.14M | $11.04B |
| Net income (latest FY) | $66.40M | $992.00M |
| Net margin | 12.8% | 9.0% |
| P/E (trailing FY) | 71.3x | 23.2x |
| SEC filings | 1,124 | 2,372 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
QUEST DIAGNOSTICS INC is 4.9x more valuable than VERACYTE, INC. by market capitalization ($23.03 B vs $4.73 B).
In their latest fiscal years, VERACYTE, INC. reported $517.14M in revenue while QUEST DIAGNOSTICS INC reported $11.04B.
Full pages: VERACYTE, INC. and QUEST DIAGNOSTICS INC, or browse the full rankings.